Fostemsavir

Records for this ingredient, by country (identity only).

ATC J05AX29 · 7 markets · 7 records

Fostemsavir 7 markets · 7 records Forms
Filters

US 1 records · 1 shown of 1 Source openFDA NDC Directory · Data as of 2026-10-23

  • 600 mgtablet · extended-releaseRukobia also in GB·CA·ES
    +1Other 1 marketsTW

GB 1 records · 1 shown of 1 Source NHSBSA dm+d · Data as of 2026-10-19

  • 600 mgtablet · extended-releaseRukobia 600mg modified-release tablets also in US·CA·ES
    +1Other 1 marketsTW

CA 1 records · 1 shown of 1 Source Health Canada Drug Product Databas · Data as of 2026-10-23

  • 600 mgtablet · extended-releaseRukobia also in US·GB·ES
    +1Other 1 marketsTW

ES 1 records · 1 shown of 1 Source CIMA (AEMPS) · Data as of live

  • 600 mgtablet · extended-releaseRukobia also in US·GB·CA
    +1Other 1 marketsTW

MX 1 records · 0 shown of 0 Source COFEPRIS · Data as of annual · some records have no stated strength

1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商

TW 1 records · 1 shown of 1 Source 衛生福利部食品藥物管理署(TFDA)全部藥品許可證資料集 · Data as of 2026-10-22

EU 1 records · 0 shown of 0 Source European Commission · Data as of 2026-11-03 · some records have no stated strength

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.

A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.